ConductScience.org, home

Paper36917951

B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity.

Laumont CM and 1 other. Cancer Cell, 2023. Cited by 228 papers, by iCite.

Cite this record

ConductScience Library. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Papers, record 36917951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36917951

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity.
PubMed
Journal
Cancer Cell
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
228
iCite
Relative citation ratio, by iCite
17.5
iCite
Revised in PubMed
2023-03-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Laumont CMCéline M
2Nelson BHBrad H

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Humans
B-Lymphocytes
Lymphocytes, Tumor-Infiltrating
T-Lymphocytes
Prognosis
Tumor Microenvironment

Source PubMed

Download CSV of topics

Cited by180

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.

PMIDTitleJournalYearIn PapersSource
42920923Senescence and tumor immunology: A multifaceted interplay of influence.iScience2026https://conductscience.org/library/papers/42920923PubMed
42872124
Integrated Multi-Time-Point 18F-FAPI PET/CT and Immune Histopathology for Predicting Pathological Complete Response in Microsatellite-Stable Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy, Chemotherapy, and Immunotherapy.
MedComm (2020)2026https://conductscience.org/library/papers/42872124PubMed
42846924The multifaceted roles of tumor-infiltrating plasma cells in cancer immunology.Fundam Res2026https://conductscience.org/library/papers/42846924PubMed
42845511Tissue-resident memory B cells augment local anti-cancer immunity via IgA.bioRxiv2026https://conductscience.org/library/papers/42845511PubMed
42830947Immune-Cell Dynamics in the Tumor Microenvironment: Implications for Cancer Therapy.MedComm (2020)2026https://conductscience.org/library/papers/42830947PubMed
42776800B Cells and Tumor Immunometabolism: Emerging Insights into Immune Regulation and Therapeutic Resistance.Antibodies (Basel)2026https://conductscience.org/library/papers/42776800PubMed
42741133Prognostic significance of the MELK/TMPO-AS1/hsa-let-7b-5p network in lung adenocarcinoma.Front Oncol2026https://conductscience.org/library/papers/42741133PubMed
42723305BRCA1/2-stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype.J Pathol Transl Med2026https://conductscience.org/library/papers/42723305PubMed
42683405CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.Ann Gastroenterol Surg2026https://conductscience.org/library/papers/42683405PubMed
42674818Multi-omics Investigations of Immune Microenvironment of Human Colorectal Cancer.Cancer Genomics Proteomics2026https://conductscience.org/library/papers/42674818PubMed
42613326Humoral immunity in cancer.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42613326PubMed
42597660B cell receptor-based hybridoma enrichment enables discovery of antibodies against intracellular tumor antigens.Front Immunol2026https://conductscience.org/library/papers/42597660PubMed
42588726Immunological and Clinical Outcomes Associated with Histotripsy Ablation in Spontaneously Occurring Canine Osteosarcoma; Veterinary Clinical Trial Results.Cancers (Basel)2026https://conductscience.org/library/papers/42588726PubMed
42571170High-titer antinuclear antibodies are associated with severe immune-related toxicity and exploratory survival outcomes in advanced gastric cancer immunotherapy.Ther Adv Med Oncol2026https://conductscience.org/library/papers/42571170PubMed
42516376Effective analysis of testicular seminoma toxicity and mechanisms of acetyl tributyl citrate using network toxicology, bulk RNA sequencing data, single-cell RNA sequencing data, and clinical data.Front Immunol2026https://conductscience.org/library/papers/42516376PubMed
42508408Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies.Cancer Cell2026https://conductscience.org/library/papers/42508408PubMed
42491333A bioinformatics analysis of KIF transcriptomic subtyping reveals prognostic heterogeneity and differential therapeutic responses in cervical cancer.Oncol Lett2026https://conductscience.org/library/papers/42491333PubMed
42487238Identification of an Immune Cell Gene Signature for Predicting Response and Prognosis in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.Cancer Med2026https://conductscience.org/library/papers/42487238PubMed
42445408A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma.Transl Cancer Res2026https://conductscience.org/library/papers/42445408PubMed
42445385Single-cell mitophagy patterns dictate intercellular crosstalk in the tumor microenvironment to promote osteosarcoma progression.Transl Cancer Res2026https://conductscience.org/library/papers/42445385PubMed

See all 180 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36917951

GET https://conductscience.org/api/papers/v1/36917951/cited_by?page=2